National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test ...

have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions our DNA, which make up the vast majority of the human genome.

An INRS team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA . A few years ago, the advent of technology known as CRISPR was a major breakthrough in the ...

Detection of tumour-derived DNA fragments in a patient's bodily fluids (circulating tumour DNA [ctDNA]) has been anticipated to revolutionise oncological care for over a decade. Because of its tumour ...

Evidence is provided to show that it is not simply the fact that males have more cell divisions in the germline, but instead, most of the mutations arise from a different balance of DNA damage vs. DNA ...

Different biomarkers play different roles in cancer research; for example, genomic mutations in a patient’s tumor could lead to specific anticancer drugs for treatment; DNA methylation and copy number ...